Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
08/2006
08/02/2006EP1684762A2 Urea derivatives as kinase modulators
08/02/2006EP1280778B1 Benzoylpyrazols and their use as herbicides
08/02/2006EP1072576B1 Fluorinating agent, process for producing the same, and use thereof
08/02/2006CN1812973A Indazole compounds useful as protein kinase inhibitors
08/02/2006CN1812967A Cathepsin cysteine protease inhibitors
08/02/2006CN1812966A N-alkynyl-2- (substituted aryloxy) alkylthioamide derivatives as fungicides
08/02/2006CN1812959A Method for producing difluoro-acetyl-acetic acid alkylesters
08/02/2006CN1812782A Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors
08/01/2006US7084178 Antiamyloid phenylsulfonamides: N-cycloalkylcarboxamides derivatives
08/01/2006US7084163 Applying to plants
08/01/2006US7083865 Containing rubrene compound and dopes; applying voltage
08/01/2006CA2276945C Tricyclic-substituted pyrazolyl benzenesulfonamides and pharmaceutical compositions thereof
08/01/2006CA2189456C Substituted aromatic thiocarboxylic acid amides and their use as herbicides
07/2006
07/27/2006WO2006077070A1 Chemical compounds, process for their preparation and use thereof
07/27/2006WO2006053555A3 Pyrazol-3-one and/or pyridazin-3-one derivatives used as inhibitors of lysyl oxidase
07/27/2006WO2006034315A3 Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
07/27/2006WO2006015263A3 Lonidamine analogs
07/27/2006WO2005120498A3 Method for synthesis of lonidamine and related indazole derivatives
07/27/2006US20060167270 5-substituted 2h-pyrazone-3-carbixylic acid derivatives as antilipolytic agents for the treatment of metabolic-related disorders such as dyslipidemia
07/27/2006US20060167053 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance
07/27/2006US20060167000 veterinary medicine; neurodegenerative diseases; Alzheimers's Disease
07/27/2006US20060166829 N-Heterocycl phenyl-substituted cyclic ketoenols
07/27/2006CA2587455A1 Substituted pyrazoles, compositions thereof, and their use as pesticides
07/26/2006EP1682538A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications
07/26/2006EP1682537A1 Modulators of cellular adhesion
07/26/2006EP1682516A2 Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets
07/26/2006EP1682515A1 Method for the production of fluoromethyl-substituted heterocycles
07/26/2006EP1682494A1 Aralkyl amines as cannabinoid receptor modulators
07/26/2006EP1682138A2 Heterocyclic inhibitors of mek and methods of use thereof
07/26/2006CN1809559A Pyrazole derivatives as phosphodiesterase 4 inhibitors
07/26/2006CN1809531A Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
07/26/2006CN1809347A Selective spirocyclic glucocorticoid receptor modulators
07/26/2006CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
07/20/2006WO2006076706A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
07/20/2006WO2006076202A1 Heterocyclic carboxamide compounds as steroid nuclear receptors ligands
07/20/2006WO2006075955A1 Pyrazolyl acylsulfonamide derivatives as endothelin converting enzyme inhibitors and useful in the treatment of chronic obstructive pulmonary disease
07/20/2006WO2006075638A1 Novel heteroaryl derivative
07/20/2006WO2006060762A3 Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
07/20/2006WO2006052546A3 Pyrazolylmethyl heteroaryl derivatives
07/20/2006WO2006007497A3 Prodrugs of mitotic kinesin inhibitors
07/20/2006US20060160858 Administering N-Cyclopropyl-2-{3-[(E)-2-(4-methyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-benzamide for treating ophthalmic disease which is age related macular degeneration, diabetic retinopathy, or neovascular glaucoma
07/20/2006US20060160856 Diarylurea derivatives and their use as chloride channel blockers
07/20/2006US20060160773 Combretastatin derivatives with cytotoxic action
07/20/2006CA2594860A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
07/20/2006CA2593156A1 Heterocyclic carboxamide compounds as steroid nuclear receptors ligands
07/19/2006EP1680411A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
07/19/2006EP1680407A1 Isopentyl carboxanilides for combating undesired micro-organisms
07/19/2006EP1680109A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
07/19/2006EP1299361B1 Pyrazole derivatives
07/19/2006CN1805950A Method for preparing fused oxazinones
07/19/2006CN1805744A New n-hydroxy-4-(3-phenyl-5-methyl-isoxazole-4-yl)-benzenesulfonamide solvates
07/18/2006US7078565 Benzamide derivatives as antagonists of orexin receptors
07/18/2006US7078531 Process for obtaining enantiomers of thienylazolylalcoxyethanamines
07/18/2006US7078426 Central nervous system disorders
07/18/2006US7078425 4-(2-substituted aminocarbonyl-2-substituted aminoethyl)-7-carboxymethoxy- indole, indazole, indoline, benzotriazole or benzoimidazole derivatives, e.g., 4-[2-Benzenesulfonylamino-2-(4-phenyl-butylcarbamoyl)-ethyl]-1H-indazol-7-yloxy}-acetic acid; treating or preventing Type II Diabetes Mellitus
07/18/2006US7078421 Substituted phenylacetic acids
07/13/2006WO2006074330A2 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
07/13/2006WO2006072785A2 Base stable ionic liquids
07/13/2006WO2006072350A1 Cyanoguanidine-substituted pyrazolines
07/13/2006US20060154988 intracellular inhibition of bacterial polypeptide deformylase in gramnegative bacteria,
07/13/2006US20060154923 N-phenyl-3-cyclopropylpyrazole-4-carbonitriles as ectoparasiticidal agents
07/13/2006US20060154897 Ophthalmic compositions for treating ocular hypertension
07/13/2006CA2594116A1 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
07/13/2006CA2588627A1 Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them
07/12/2006EP1679308A1 Novel indazole derivative
07/12/2006EP1678143A2 N-substituted pyrazolyl carboxanilides
07/12/2006EP1678142A1 Hexyl carboxanilides and their use for controlling undesirable micro-organisms
07/12/2006EP1678141A1 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms
07/12/2006EP1678119A1 Method for producing 2-dihaloacyl-3-amino-acrylic acid esters and 3-dihalomethyl-pyrazole-4-carboxylic acid esters
07/12/2006CN1802373A Pyrazoloisoquinoline derivatives as kinase inhibitors
07/12/2006CN1800185A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes.
07/11/2006US7074867 Ion conducting polymers
07/11/2006US7074805 Especially isoquinolin-5-ylurea derivatives; treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.
07/11/2006CA2168447C Compounds and methods for inhibition of hiv and related viruses
07/06/2006WO2006071730A1 Pyrazolone compounds as metabotropic glutamate receptor agonists for the treatment of neurological and psychiatric disorders
07/06/2006WO2006070878A1 Carboxylic acid derivative or salt thereof
07/06/2006WO2006069809A1 Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments
07/06/2006WO2006069808A2 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments
07/06/2006WO2006069807A1 Substituted phenyl-piperazine compounds, their preparation and use in medicaments
07/06/2006WO2006069766A1 Process for obtaining enantiomers of cizolirtine
07/06/2006WO2006069656A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation
07/06/2006WO2005105096A3 Fused heterocyclic compounds
07/06/2006US20060149091 Method for producing difluoro-acetyl-acetic acid alkylesters
07/06/2006US20060148876 Nr3b1 nuclear receptor binding 3-substituted pyrazoles
07/06/2006US20060148858 1, 2-Azole derivatives with hypoglycemic and hypolipidemic activity
07/06/2006US20060148817 Pyrazole compounds
07/06/2006DE102004061751A1 Cyanoguanidin-substituierte Pyrazoline Cyanoguanidino substituted pyrazolines
07/06/2006CA2592858A1 Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments
07/06/2006CA2592852A1 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments
07/06/2006CA2592832A1 Substituted phenyl-piperazine compounds, their preparation and use in medicaments
07/06/2006CA2592514A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
07/06/2006CA2592430A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation
07/06/2006CA2591003A1 Pyrazolone compounds as metabotropic glutamate receptor agonists for the treatment of neurological and psychiatric disorders
07/05/2006EP1676842A1 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments
07/05/2006EP1676841A1 Substitited indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their prepartion and use in medicaments
07/05/2006EP1676834A1 Fused bicyclic carboxamide derivates for use as CXCR2 inhibitors in the treatment of inflammation
07/05/2006EP1675844A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
07/05/2006EP1675832A1 Heterocyclyl compounds
07/05/2006EP1675587A2 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain
07/05/2006EP1675585A2 Large conductance calcium-activated k channel opener